Try our mobile app
 |
Dr. Reddy’s Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, CIN : L85195TG1984PLC004507
Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.com |
May 19, 2022
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc.(Stock Code :RDY)
NSE IFSC Ltd.
Dear Sir/Madam,
Sub: Outcome of Board Meeting held on May 19, 2022
In furtherance to our letter dated March 29, 2022, we would like to inform you that the Board of Directors of the Company at their meeting held on May 19, 2022, has, inter alia, transacted the following businesses:
Financial Results
| A. | Approved the Audited Financial Results of the Company for the quarter and year ended March 31, 2022. |
In terms of the above, we are enclosing herewith the following:
| 1. | Audited Consolidated Financial Results of the Company and its subsidiaries for the quarter and year ended March 31, 2022 as per International Financial Reporting Standards (IFRS) as issued by International Accounting Standards Board (IASB). |
| 2. | Press Release on Financial Results of the Company for the above period. |
| 3. | Audited Consolidated Financial Results of the Company and its subsidiaries for the quarter and year ended March 31, 2022 as per Indian Accounting Standards. |
| 4. | Audited Standalone Financial Results of the Company for the quarter and year ended March 31, 2022 as per Indian Accounting Standards. |
Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Audit Report of the Statutory Auditors on the financial results as mentioned at serial nos. 3 & 4 are also enclosed.
We would like to confirm that the Statutory Auditors of the Company, have issued Audit Reports with 'Unmodified Opinion' on the Audited Financial Statements of the Company (Standalone and Consolidated) for the year ended March 31, 2022.
 |
Dividend
| B. | Recommended a final dividend of Rs.30/- (600%) per equity share of Rs. 5/- each for the financial year 2021-22. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 38th Annual General Meeting (AGM). |
The Board Meeting commenced at 10.15 AM and concluded at 12.28 PM.
This is for your information and record.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
| /s/ K Randhir Singh | ||
| K Randhir Singh | ||
| Company Secretary & Compliance Officer |
Encl: As above
